Dana El-Kurd

In 2024, an anti-abortion organization, the Alliance for Hippocratic Medicine, intentionally incorporated in 2022 an Amarillo,

which placed it in the jurisdiction of the famously anti-abortion federal district judge Matthew J. Kaczmarek.

Like Judge Ho, Kaczmarek belonged to the First Liberty Institute.

While being considered for the federal bench, he unsuccessfully tried to conceal his authorship of legal articles on gay rights he thought might jeopardize approval of his nomination by the U.S.

Senate.

Kaczmarek has described gay and trans people as mentally disordered.

The Alliance for Hippocratic Medicine filed suit in Kaczmarek's court seeking to overturn the FDA's approval of mifepristone, even though decades of research had demonstrated its safety and its effectiveness for treating Cushing syndrome, a severe endocrine disorder.

None of the doctors in the alliance had ever been involved in a medical case in which the use of mifeprestone had been considered.

In his opinion, Kazmirik showed his disdain for medical personnel providing women reproductive care, referring to them as, quote, abortionists, and called terminating pregnancy through medication, quote, starving the unborn human until death.

Courts require that parties have what judges call standing in order to file a lawsuit.

That means, for instance, that one party has been in some way directly injured by the other party.

President Joe Biden's Food and Drug Administration questioned how the doctors in the Alliance for Hippocratic Medicine had in any way been directly harmed because women have access to abortion medications.

Kaczmarek found a fanciful way to grant the alliance a right to sue.

He claimed that treating the rare complications from Mifepristone overwhelmed hospitals and placed, quote, enormous pressure and stress on the doctors during emergencies and complications.

After granting the alliance standing, Kaczmarek issued a preliminary injunction suspending the FDA's approval of the drug.

The decision would go into effect in seven days in order to give the federal government a chance to file an appeal.

In his decision, Kaczmarek cited two studies that claimed the drug was harmful, but both had been retracted by a medical journal.

In effect, Kaczmarek had banned Mifepristone nationwide.

The United States Justice Department and Danco Laboratories, Mifepristone's manufacturer, appealed, and the case went to the Fifth Circuit.

Judicial chaos surrounding the status of Mifepristone reigned within hours as ABC7 in Los Angeles reported.